Assessment of Maternal and Fetal Dolutegravir Exposure by Integrating Ex Vivo Placental Perfusion Data and Physiologically-Based Pharmacokinetic Modeling

MLA

Freriksen, J. J. M., et al. “Assessment of Maternal and Fetal Dolutegravir Exposure by Integrating Ex Vivo Placental Perfusion Data and Physiologically-Based Pharmacokinetic Modeling.” Clinical Pharmacology and Therapeutics, 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1284058397&authtype=sso&custid=ns315887.

APA

Freriksen, J. J. M., Schalkwijk, S. J., Colbers, A. P., Abduljalil, K., Russel, F. G. M., Burger, D. M., & Greupink, R. (2020). Assessment of Maternal and Fetal Dolutegravir Exposure by Integrating Ex Vivo Placental Perfusion Data and Physiologically-Based Pharmacokinetic Modeling. Clinical Pharmacology and Therapeutics.

Chicago

Freriksen, J.J.M., S.J. Schalkwijk, A.P. Colbers, K. Abduljalil, F.G.M. Russel, D.M. Burger, and R. Greupink. 2020. “Assessment of Maternal and Fetal Dolutegravir Exposure by Integrating Ex Vivo Placental Perfusion Data and Physiologically-Based Pharmacokinetic Modeling.” Clinical Pharmacology and Therapeutics. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1284058397&authtype=sso&custid=ns315887.